Efficacy and Safety of Sleep-Promoting Agents-Reference-Cited by-同舟云学术

Efficacy and Safety of Sleep-Promoting Agents

Published:2008-06 Issue:2 Volume:3 Page:175-187
ISSN:1556-407X
Container-title:Sleep Medicine Clinics
language:en
Short-container-title:Sleep Medicine Clinics

Author:

Roth Thomas,Roehrs Timothy

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Neurology,Clinical Psychology,General Medicine,Neuropsychology and Physiological Psychology

Reference94 articles.

1. State of the science conference statement on manifestations and management of chronic insomnia in adults June 13–15, 2005;National Institutes of Health;Sleep,2005

2. Diagnostic and statistical manual of mental disorders;American Psychiatric Association,2000

3. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine work group;Edinger;Sleep,2004

4. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life and work limitations;Walsh;Sleep,2007

5. Ramelteon (TAK-375), a selective MT1/MT2-receptor against, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment;Roth;Sleep,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzodiazepines: Their Use either as Essential Medicines or as Toxics Substances;Toxics;2021-02-01

2. Chapter 46: Insomnia, Drowsiness, and Fatigue;Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 18th Edition;2015-01

3. Management of over-the-counter insomnia complaints in Australian community pharmacies: a standardized patient study;International Journal of Pharmacy Practice;2013-08-15

4. Can a community pharmacy sleep assessment tool aid the identification of patients at risk of sleep disorders in the community: a pilot study;Integrated Pharmacy Research and Practice;2012-11

5. Management of Insomnia;Essentials of Sleep Medicine;2011-09-24